Cargando…

Machine learning-based prediction of breast cancer growth rate in vivo

BACKGROUND: Determining the rate of breast cancer (BC) growth in vivo, which can predict prognosis, has remained elusive despite its relevance for treatment, screening recommendations and medicolegal practice. We developed a model that predicts the rate of in vivo tumour growth using a unique study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhattarai, Shristi, Klimov, Sergey, Aleskandarany, Mohammed A., Burrell, Helen, Wormall, Anthony, Green, Andrew R., Rida, Padmashree, Ellis, Ian O., Osan, Remus M., Rakha, Emad A., Aneja, Ritu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738119/ https://www.ncbi.nlm.nih.gov/pubmed/31395950 http://dx.doi.org/10.1038/s41416-019-0539-x

Ejemplares similares

Novel immunohistochemistry-based signatures to predict metastatic site of triple-negative breast cancers
por: Klimov, Sergey, et al.
Publicado: (2017)

A whole slide image-based machine learning approach to predict ductal carcinoma in situ (DCIS) recurrence risk
por: Klimov, Sergey, et al.
Publicado: (2019)

Combined HER3-EGFR score in triple-negative breast cancer provides prognostic and predictive significance superior to individual biomarkers
por: Ogden, Angela, et al.
Publicado: (2020)

Panoptic Overview of Triple-Negative Breast Cancer in Nigeria: Current Challenges and Promising Global Initiatives
por: Wright, Nikita, et al.
Publicado: (2018)

KIFCI, a novel putative prognostic biomarker for ovarian adenocarcinomas: delineating protein interaction networks and signaling circuitries
por: Pawar, Shrikant, et al.
Publicado: (2014)

Rampant centrosome amplification underlies more aggressive disease course of triple negative breast cancers
por: Pannu, Vaishali, et al.
Publicado: (2015)

Predicting Metastasis Risk in Pancreatic Neuroendocrine Tumors Using Deep Learning Image Analysis
por: Klimov, Sergey, et al.
Publicado: (2021)

Distinctions in Breast Tumor Recurrence Patterns Post-Therapy among Racially Distinct Populations
por: Wright, Nikita, et al.
Publicado: (2017)

Multi-institutional study of nuclear KIFC1 as a biomarker of poor prognosis in African American women with triple-negative breast cancer
por: Ogden, Angela, et al.
Publicado: (2017)

Hypoxia-Induced Centrosome Amplification Underlies Aggressive Disease Course in HPV-Negative Oropharyngeal Squamous Cell Carcinomas
por: Mittal, Karuna, et al.
Publicado: (2020)

Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study
por: Bhattarai, Shristi, et al.
Publicado: (2019)

Prognostic value of CA20, a score based on centrosome amplification-associated genes, in breast tumors
por: Ogden, Angela, et al.
Publicado: (2017)

A Case Series Exploration of Multi-Regional Expression Heterogeneity in Triple-Negative Breast Cancer Patients
por: Xu, Qi, et al.
Publicado: (2022)

Amplified centrosomes and mitotic index display poor concordance between patient tumors and cultured cancer cells
por: Mittal, Karuna, et al.
Publicado: (2017)

The more the messier: centrosome amplification as a novel biomarker for personalized treatment of colorectal cancers
por: Mahathre, Monica M., et al.
Publicado: (2016)

Hypoxia Drives Centrosome Amplification in Cancer Cells via HIF1α-dependent Induction of Polo-Like Kinase 4
por: Mittal, Karuna, et al.
Publicado: (2022)

Quadruple-negative breast cancer: novel implications for a new disease
por: Bhattarai, Shristi, et al.
Publicado: (2020)

Quadruple-Negative Breast Cancer: An Uneven Playing Field
por: Saini, Geetanjali, et al.
Publicado: (2020)

DNA damage response markers are differentially expressed in BRCA-mutated breast cancers
por: Aleskandarany, Mohammed, et al.
Publicado: (2015)

Rho-GTPase activating-protein 18: a biomarker associated with good prognosis in invasive breast cancer
por: Aleskandarany, Mohammed A, et al.
Publicado: (2017)

Chemokine (C‐C motif) receptor 7 (CCR7) associates with the tumour immune microenvironment but not progression in invasive breast carcinoma
por: Sonbul, Sultan N, et al.
Publicado: (2017)

Panoptic View of Prognostic Models for Personalized Breast Cancer Management
por: Saini, Geetanjali, et al.
Publicado: (2019)

A centrosome clustering protein, KIFC1, predicts aggressive disease course in serous ovarian adenocarcinomas
por: Mittal, Karuna, et al.
Publicado: (2016)

Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer
por: Aleskandarany, Mohammed A, et al.
Publicado: (2012)

Prevalence and Mortality of Triple-Negative Breast Cancer in West Africa: Biologic and Sociocultural Factors
por: Nwagu, Gift C., et al.
Publicado: (2021)

Efficacy based ginger fingerprinting reveals potential antiproliferative analytes for triple negative breast cancer
por: Zhao, Lihan, et al.
Publicado: (2020)

The prognostic significance of BMI1 expression in invasive breast cancer is dependent on its molecular subtypes
por: Althobiti, Maryam, et al.
Publicado: (2020)

SARS-CoV-2 Infection in Cancer Patients: Effects on Disease Outcomes and Patient Prognosis
por: Seth, Gaurav, et al.
Publicado: (2020)

Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer
por: Althobiti, Maryam, et al.
Publicado: (2021)

Digital image analysis and machine learning-assisted prediction of neoadjuvant chemotherapy response in triple-negative breast cancer
por: Fisher, Timothy B., et al.
Publicado: (2023)

QNBC Is Associated with High Genomic Instability Characterized by Copy Number Alterations and miRNA Deregulation
por: Bhattarai, Shristi, et al.
Publicado: (2021)

Single and multiple-spikes traveling wave solutions in integrate and fire neural networks
por: Oşan, Remus
Publicado: (2007)

Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections
por: Muftah, Abir A., et al.
Publicado: (2017)

The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer
por: Aljohani, Abrar I., et al.
Publicado: (2019)

Clinicopathologic and molecular predictors of axillary lymph node metastasis in early-stage breast cancer: a mathematical predictive model
por: Aleskandarany, MA, et al.
Publicado: (2010)

Deep learning based registration of serial whole-slide histopathology images in different stains
por: Roy, Mousumi, et al.
Publicado: (2023)

Quantitative multi-parametric evaluation of centrosome declustering drugs: centrosome amplification, mitotic phenotype, cell cycle and death
por: Ogden, A, et al.
Publicado: (2014)

Co-expression of nuclear P38 and hormone receptors is prognostic of good long-term clinical outcome in primary breast cancer and is linked to upregulation of DNA repair
por: Johnston, Simon J., et al.
Publicado: (2018)

Exosomal Metabolic Signatures Are Associated with Differential Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer
por: Joshi, Shriya, et al.
Publicado: (2022)

PLK1 and AURKB phosphorylate survivin differentially to affect proliferation in racially distinct triple-negative breast cancer
por: Garlapati, Chakravarthy, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jtcj00jpfbcirb5q7635velc3b